http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012120833-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04 |
filingDate | 2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2012120833-A |
titleOfInvention | COMPOSITIONS BASED ON HYPERSULPHATED DISACCHARIDES |
abstract | 1. A pharmaceutical composition comprising a compound of Formula I and pharmaceutically acceptable salts of R, R, R, R, R, and R are independently selected from the group consisting of H, SOH, or POH, provided that at least two of R-R are selected from SOH or RON, and delivery agent. 2. The composition according to claim 1, characterized in that at least three of R-R are selected from SOH or POH. 3. The composition according to claim 1, characterized in that at least four of the R-R are selected from SOH or RON. The composition according to claim 1, characterized in that at least five of R1-R6 are selected from SOH or POH. The composition according to claim 1, characterized in that R-R are selected from SOH or POH. 6. A pharmaceutical composition containing a compound of formula I and its pharmaceutically acceptable R, R, R, R and R and R independently are independently selected from H, SOH, or POH, and R3 is independently selected from SOH or POH, and a delivery agent. A pharmaceutical composition containing a compound of formula I and its pharmaceutically acceptable R, R, R, and R moieties are independently selected from H, SOH, or POH, and R and R are independently selected from SOH or POH, and a delivery agent selected from the group consisting of a pharmaceutically acceptable natural or synthetic polymer. 8. A pharmaceutical composition containing (i) a compound of formula I and its pharmaceutically acceptable solids where R, R, and R are independently selected from H, SOH, or POH, and R, R and R are independently selected from SOH or POH, and (ii) a delivery agent. A pharmaceutical composition comprising (i) a compound of formula II and pharmaceutically acceptable salts thereof, wherein R, R, P, R and R are independently selected from the group consisting of H, SOH or POH, and (ii) a delivery agent. A composition comprising a compound of formula I wherein R-R are pharmaceutically acceptable salts thereof and a delivery agent selected from a hydrophilic polymer. 11. The composition of claim 10, wherein |
priorityDate | 2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.